Euronext Takes Stake in LCH’s French Clearinghouse

European exchange group Euronext has signed a deal for clearing services with LCH, scuppering a previous agreement with ICE

lse1
Euronext's deal with LCH SA will last for 10 years but comes with important rights regarding any future sale.

Pan-European exchange operator Euronext has signed a ten-year deal with LCH SA, majority owned by the London Stock Exchange Group (LSEG), which will see the central counterparty (CCP) provide clearing services for listed financial and commodity derivatives. As part of the deal, Euronext will exchange its existing 2.3 percent stake in the wider LCH Group for 11.1 percent of the Paris-based SA business.

“This is essentially an agreement to renew the contract with LCH,” says Lee Hodgkinson, CEO of

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Systematic tools gain favor in fixed income

Automation is enabling systematic strategies in fixed income that were previously reserved for equities trading. The tech gap between the two may be closing, but differences remain.

Why recent failures are a catalyst for DLT’s success

Deutsche Bank’s Mathew Kathayanat and Jie Yi Lee argue that DLT's high-profile failures don't mean the technology is dead. Now that the hype has died down, the path is cleared for more measured decisions about DLT’s applications.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here